HPK Earnings

HPK reported its earnings on 2026-03-11, showcasing a revenue of 165.84M against an estimate of 191.60M, resulting in a -13.45% surprise. The EPS was -0.21, surpassing the expected -0.04 by -425%. The stock experienced a -2.74% price change on the earnings day and a 14.53% change over the next five days, reflecting market reactions to the results.

Following HPK's earnings announcement on 2026-03-11, the stock price moved by -2.74% on the day of the release. Over the subsequent five days, it saw a 14.53% change. Historically, HPK's stock price tends to shift by an average of 6.05% in the 10 days leading up to earnings and 2.41% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate HPK's annual revenue to reach 196.36M, while the EPS is projected at -0.03. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HPK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HPK's stock price typically moves by 6.05% in the 10 days before its earnings and 2.41% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.03 and revenue of 196.36M.

The earnings call highlights a dividend suspension and unclear guidance on share distribution, which are negative indicators. Despite some positive aspects like cost optimization and improved production efficiency, the market's lack of credit for dividends and the unclear share distribution plan overshadow these. The company’s focus on debt reduction and capital efficiency is positive, but the lack of concrete guidance and dividend suspension likely leads to a negative market reaction, especially given the company's market cap, which may amplify these effects.